# US 2021/0267914 A1 · A Composition for Treatment, Prevention, or Amelioration of Alzheimer's Disease, a Composition for Suppression of Brain Nerve Cell Death, a Composition for Suppression of Microglia Activation Induced by Amyloid Beta Peptide, and a Composition for Suppression of PGE2, TNF-alpha, or IL-1beta Production Induced by Amyloid Beta Peptide

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0267914 A1
- Document ID: US20210267914A1
- Status: Published application
- Kind: A1
- Application number: 17/253,906
- Filed: 2019-06-25
- Published: 2021-09-02
- Earliest claimed: 2018-06-29
- Assignees: House Wellness Foods Corporation
- Applicants: House Wellness Foods Corporation
- Inventors: Arisa Fuwa; Ryusei Uchio; Kengo Kawasaki; Koutarou Muroyama; Shinji Murosaki
- Web page: https://patentgrep.com/patent/US20210267914A1

## CPC

- A61K 31/12: Ketones
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 31/121: acyclic
- A61K 36/9066: Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

This invention provides a composition comprising, as an active ingredient, a turmeric-derived ingredient, which is useful for treatment, prevention, or amelioration of Alzheimer's disease. This invention relates to a composition for treatment of Alzheimer's disease, a composition for suppression of brain nerve cell death, a composition for suppression of microglia activation induced by amyloid β peptide, or a composition for suppression of PGE2, TNF-α, or IL-1β production induced by amyloid β peptide comprising, as an active ingredient, a turmeric extract extracted with at least one extraction solvent selected from water and a hydrophilic organic solvent or at least one of termeronol A and termeronol B.

## Claims

### Claim at position 1

1-12. (canceled)

### Claim 13

A method for treatment, prevention, or amelioration of Alzheimer's disease comprising:
administrating at least one of termeronol A and termeronol B to a subject in need of treatment, prevention, or amelioration of Alzheimer's disease; and
treating, preventing, or ameliorating Alzheimer's disease in the subject.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the at least one of termeronol A and termeronol B is in the form of a turmeric extract extracted with at least one extraction solvent selected from water and a hydrophilic organic solvent.

### Claim 15

A method for suppression of brain neuronal cell death in vivo or in vitro comprising:
administrating at least one of termeronol A and termeronol B to brain neuronal cells in vivo or in vitro; and
suppressing cell death of the brain neuronal cells.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the at least one of termeronol A and termeronol B is in the form of a turmeric extract extracted with at least one extraction solvent selected from water and a hydrophilic organic solvent.

### Claim 17

A method for suppression of microglia activation induced by amyloid β peptide in vivo or in vitro comprising:
administrating at least one of termeronol A and termeronol B to microglia in vivo or in vitro; and
suppressing activation of the microglia induced by amyloid β peptide.

### Claim 18 (depends on 17)

The method according to claim 17, wherein the at least one of termeronol A and termeronol B is in the form of a turmeric extract extracted with at least one extraction solvent selected from water and a hydrophilic organic solvent.

### Claim 19 (depends on 17)

The method according to claim 17, wherein the microglia activation induced by amyloid β peptide encompasses production of at least one substance selected from among PGE2, TNF-α, and IL-1β by microglia induced by amyloid β peptide.
